Abstract: The disclosed technology provides solutions for providing an accurate pick-up location for an autonomous vehicle and a rider during a ride hailing pick-up. A method of the disclosed technology can include steps for determining map information associated with at least one thoroughfare for routing an autonomous vehicle, wherein the map information is based on location data associated with a client device requesting the autonomous vehicle; receiving sensor data from the client device corresponding to the at least one thoroughfare; determining, based on the sensor data and the map information, a first position of the client device relative to the at least one thoroughfare; and routing the autonomous vehicle based on the first position of the client device relative to the at least one thoroughfare. Systems and machine-readable media are also provided.

Abstract: A patient interface for delivery of a supply of pressurised air or breathable gas to an entrance of a patient's airways comprising: a cushion member that includes a retaining structure and a seal-forming structure permanently connected to the retaining structure; a frame member attachable to the retaining structure; and a positioning and stabilising structure attachable to the frame member.

Abstract: Opinion polling systems and methods are described herein. The polling method includes posting a poll to the opinion polling system for display as a poll on user devices and monitoring user parameters associated with a respondent to the poll. The method further includes calculating a user strength score for the respondent based on the user parameters and identifying the respondent as a bot based on the user strength score. Once identified as a bot, the respondent is blocked from further participation on the opinion polling system. In some cases, the method includes calculating a price for purchasing data from the poll based on a volume of the data to be purchased and determining a monetary compensation for the user that posted the poll.

Abstract: A patient interface for delivery of a supply of pressurised air or breathable gas to an entrance of a patient's airways comprising: a cushion member that includes a retaining structure and a seal-forming structure permanently connected to the retaining structure; a frame member attachable to the retaining structure; and a positioning and stabilising structure attachable to the frame member.

Abstract: Embodiments herein provide methods, systems, suitable for the analysis of both complex and conventional data pertaining to an individual user or human activity that is received in real-time and/or in batches from a variety of data source types, to identify and produce results that benefit the individual user. One general aspect includes a method comprising: receiving input data from a plurality of peripheral devices, e.g., one or more interface devices for a user device; analyzing the input data to generate a plurality of data analysis streams of time-series data relating to a user of for a first period of time; generating a plurality of user or system generated insight based time tags for second periods of time within the first period of time; and generating a dashboard for display to the user.

Abstract: Disclosed herein is a drug-coated medical device in the form of a balloon having an inner surface and an outer hydrophobic surface, an adhesion balance layer directly on the outer hydrophobic surface of the balloon, comprising a hydrophilic polymer and/or a hydrophilic compound where the hydrophilic compound has a molecular weight of less than 1,000 Daltons, and a therapeutic layer directly on the adhesion balance layer comprising a therapeutic agent and a pharmaceutically acceptable carrier, wherein the therapeutic agent is a hydrophobic therapeutic agent with one or more hydrogen-bonding groups and is provided as discrete drug particles in the therapeutic layer, the drug particles have at least one dimension that is less than 25 µm and are uniformly distributed on the surface of the balloon, and the pharmaceutically acceptable carrier is hydrophilic and has a molecular weight of less than 1,000 Daltons. A process to make the drug-coated medical device and uses thereof are also disclosed.

Abstract: A communications ecosystem and related methods of operation include an ecosystem safety level (ESL), a plurality of vehicles or systems, each vehicle or system having an individual safety level (ISL), a control system operable to determine whether the ISL for each vehicle or system meets or exceeds the ESL, and one or more communications links between any first vehicle or system having a first ISL that does not meet or exceed the ESL and a second vehicle or system with a second ISL that does meet or exceed the ESL such that the first vehicle or system operates at the second ISL.

Abstract: Provided herein are methods, devices, compositions, and kits for monitoring neuromodulation efficacy based on changes in the level or activity of one or more target biomarkers.

Abstract: Provided herein are methods, devices, compositions, and kits for monitoring neuromodulation efficacy based on changes in the level or activity of one or more target biomarkers. One aspect includes a comparison of baseline and post-modulation levels of one or more biomarkers in bodily fluid that have each been collected from a human subject at a relevant time, and that may be used to assess the neuromodulation efficacy. The post-neuromodulation levels for the one or more biomarkers may be collected from the human subject within about 5 minutes to about 14 days post-neuromodulation.

Abstract: A communications ecosystem and related methods of operation include an ecosystem safety level (ESL), a plurality of vehicles or systems, each vehicle or system having an individual safety level (ISL), a control system operable to determine whether the ISL for each vehicle or system meets or exceeds the ESL, and one or more communications links between any first vehicle or system having a first ISL that does not meet or exceed the ESL and a second vehicle or system with a second ISL that does meet or exceed the ESL such that the first vehicle or system operates at the second ISL.

Abstract: A method for managing the servicing of vehicles in a fleet includes using a mobile device associated with a vehicle to be serviced to contact a fleet call center. The contact is received and a service request is opened in the fleet call center. A local servicer is identified, and information in the service request is sent to a data device of a service technician of the local servicer. Upon completion of servicing of the vehicle, a notification of completion of the service request is sent to a service administrator. The notification is validated to generate a completed service request, and information in the completed service request is sent from the service administrator to an approver of a fleet operations unit. The completed service request is approved at the fleet operations unit, and a purchase order is generated and transmitted from the fleet operations unit to the service administrator.

Abstract: The disclosed principles provide for an improved bedsheet capable of staying attached to any mattress, and thus not be removable from the mattress during normal use. A sheet as disclosed herein replaces the conventional fitted sheet on which a person sleeps and is attached at the four corners around the bed's mattress. A sheet as disclosed herein features a “pocket” formed at the head of the sheet that is used to secure the sheet, rather than the typical elasticized corners of a conventional fitted sheet that merely grasps the corners and/or bottom at the head of the mattress. By replacing the elasticized parts at the head of the lower bedsheet with the disclosed pocket, the entire head of the mattress, not just the corners, are secured within the pocket of the disclosed sheet. Thus, the disclosed pocketed lower bedsheet will not come loose from the mattress during its normal use.

Abstract: Methods for treating a patient using therapeutic renal neuromodulation and associated devices, systems, and methods are disclosed herein. One aspect of the present technology is directed to biomarker sampling in the context of neuromodulation devices, systems, and methods. Some embodiments, for example, are directed to catheters, catheter systems, and methods for sampling biomarkers that change in response to neuromodulation. A system can include, for example, an elongated shaft and a neuromodulation and sampling assembly having a neuromodulation and a sampling element.

Abstract: Methods for treating a patient using therapeutic renal neuromodulation and associated devices, systems, and methods are disclosed herein. One aspect of the present technology is directed to biomarker sampling in the context of neuromodulation devices, systems, and methods. Some embodiments, for example, are directed to catheters, catheter systems, and methods for sampling biomarkers that change in response to neuromodulation. A system can include, for example, an elongated shaft and a neuromodulation and sampling assembly having a neuromodulation and a sampling element.

Abstract: A method for managing the servicing of vehicles in a fleet includes using a mobile device associated with a vehicle to be serviced to contact a fleet call center. The contact is received and a service request is opened in the fleet call center. A local servicer is identified, and information in the service request is sent to a data device of a service technician of the local servicer. Upon completion of servicing of the vehicle, a notification of completion of the service request is sent to a service administrator. The notification is validated to generate a completed service request, and information in the completed service request is sent from the service administrator to an approver of a fleet operations unit. The completed service request is approved at the fleet operations unit, and a purchase order is generated and transmitted from the fleet operations unit to the service administrator.

Abstract: An inspection system for a tire of a vehicle in a fleet includes a portable inspection device that includes means for measuring a tire pressure, means for measuring a tread depth of the tire, and an antenna for wireless communication. A hand-held data device includes a processor, memory and an antenna. The data device receives the measured tire pressure and the measured tread depth of the tire from the portable inspection device. A server is remote from the data device and a first wireless transmission means uploads the measured tire pressure and the measured tread depth of the tire from the data device to the server. An analysis device is in electronic communication with the server for analysis of the data uploaded from the data device. A second wireless transmission means communicates cloned data sets from the server to the data device. A method for inspecting is also provided.

Abstract: Provided herein are methods, devices, compositions, and kits for monitoring neuromodulation efficacy based on changes in the level or activity of one or more target biomarkers.

Abstract: There is provided systems and method for an electronic payment to a non-Internet connected device. The methods include transmitting information corresponding to at least one item for sale at a non-Internet connected machine, receiving a purchase request from a user device for the at least one item from the non-Internet connected machine, and communicating, using a hardware processor of a payment provider server, an approval of the purchase request to the user device, wherein the user device is configured to transmit a purchase authorization to the non-Internet connected machine using a wireless connection.

Abstract: Disclosed herein is a drug-coated medical device in the form of a balloon having an inner surface and an outer hydrophobic surface, an adhesion balance layer directly on the outer hydrophobic surface of the balloon, comprising a hydrophilic polymer and/or a hydrophilic compound where the hydrophilic compound has a molecular weight of less than 1,000 Daltons, and a therapeutic layer directly on the adhesion balance layer comprising a therapeutic agent and a pharmaceutically acceptable carrier, wherein the therapeutic agent is a hydrophobic therapeutic agent with one or more hydrogen-bonding groups and is provided as discrete drug particles in the therapeutic layer, the drug particles have at least one dimension that is less than 25 ??? and are uniformly distributed on the surface of the balloon, and the pharmaceutically acceptable carrier is hydrophilic and has a molecular weight of less than 1,000 Daltons. A process to make the drug-coated medical device and uses thereof are also disclosed.